• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血红蛋白病筛查:镰状细胞病卓越中心的初步经验

Screening for Hemoglobinopathies: An Inceptive Experience of Centre of Excellence for Sickle Cell Disease.

作者信息

Vishnoi Anita, Jyani Ritvika, Sharma Ayushi, Poswal Lakhan, Goyal Shuchi, Swami Shelesh Kumar, Chauhan Nitesh Kumar

机构信息

Department of Pediatrics, RNT Medical College, Udaipur, Rajasthan, 313001, India.

Centre of Excellence for Sickle Cell Disease, RNT Medical College, Udaipur, Rajasthan, India.

出版信息

Indian Pediatr. 2025 Sep 8. doi: 10.1007/s13312-025-00178-3.

DOI:10.1007/s13312-025-00178-3
PMID:40920308
Abstract

OBJECTIVE

To estimate the prevalence of various hemoglobinopathies among newborns, women in antenatal clinic and children presenting with signs and symptoms suggestive of sickle cell disease (SCD).

METHODS

A hospital-based prospective study was conducted at a Centre of Excellence for SCD (COESCD). Dried blood spot (DBS) samples were collected for newborn screening using heel-prick and venous samples were used in the post-neonatal age group. Hemoglobin variant analysis was performed using high-performance liquid chromatography (HPLC).

RESULTS

Out of 26,642 neonates screened, 1.87% (n = 498) were found to have abnormal hemoglobin patterns. The prevalence of hemoglobin variants detected among women screened during antenatal check-up and children with signs and symptoms of SCD were found to be 6.11% and 22.69%, respectively.

CONCLUSION

Intensive screening programs have led to detection of a large number of cases with hemoglobinopathies including rare hemoglobin variants.

摘要

目的

评估新生儿、产前门诊妇女以及出现镰状细胞病(SCD)体征和症状的儿童中各种血红蛋白病的患病率。

方法

在一个镰状细胞病卓越中心(COESCD)开展了一项基于医院的前瞻性研究。采用足跟采血收集干血斑(DBS)样本用于新生儿筛查,在新生儿期后年龄组使用静脉血样本。使用高效液相色谱法(HPLC)进行血红蛋白变异体分析。

结果

在筛查的26642例新生儿中,发现1.87%(n = 498)有异常血红蛋白模式。在产前检查期间筛查的妇女以及有SCD体征和症状的儿童中检测到的血红蛋白变异体患病率分别为6.11%和22.69%。

结论

强化筛查项目已导致检测出大量血红蛋白病病例,包括罕见的血红蛋白变异体。

相似文献

1
Screening for Hemoglobinopathies: An Inceptive Experience of Centre of Excellence for Sickle Cell Disease.血红蛋白病筛查:镰状细胞病卓越中心的初步经验
Indian Pediatr. 2025 Sep 8. doi: 10.1007/s13312-025-00178-3.
2
Sickle Cell Disease镰状细胞病
3
MALDI-MS in first-line screening of newborns for sickle cell disease: results from a prospective study in comparison to HPLC.MALDI-MS 在新生儿镰状细胞病一线筛查中的应用:与 HPLC 比较的前瞻性研究结果。
Clin Chem Lab Med. 2024 Feb 5;62(6):1149-1157. doi: 10.1515/cclm-2023-1250. Print 2024 May 27.
4
Development of a low-cost and high-throughput LC-MS method for newborn screening of thalassemia and abnormal hemoglobin disorders.开发一种用于地中海贫血和异常血红蛋白疾病新生儿筛查的低成本、高通量液相色谱-质谱联用方法。
World J Pediatr. 2025 Sep 1. doi: 10.1007/s12519-025-00962-y.
5
Beta-Thalassemiaβ地中海贫血
6
Strategies of testing for syphilis during pregnancy.孕期梅毒检测策略。
Cochrane Database Syst Rev. 2014 Oct 29;2014(10):CD010385. doi: 10.1002/14651858.CD010385.pub2.
7
Prenatal hemoglobinopathy screening & prevention in India: A cross-sectional study.印度的产前血红蛋白病筛查与预防:一项横断面研究。
Indian J Med Res. 2025 May;161(5):441-448. doi: 10.25259/IJMR_1003_2024.
8
Laser therapy for retinopathy in sickle cell disease.激光疗法治疗镰状细胞病视网膜病变。
Cochrane Database Syst Rev. 2022 Dec 12;12(12):CD010790. doi: 10.1002/14651858.CD010790.pub3.
9
The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women.人乳头瘤病毒基因分型检测在日本女性自行采集的尿液和阴道样本癌症筛查中的效用
Gynecol Obstet Invest. 2025;90(2):143-152. doi: 10.1159/000541641. Epub 2024 Oct 7.
10
Magnitude of Beta-Hemoglobinopathies through Biomarkers among the Selected Tribes of Dharmapuri, Tamil Nadu: A Community-Based Cross-Sectional Study.通过生物标志物评估泰米尔纳德邦达马普里特定部落中β-地中海贫血的严重程度:一项基于社区的横断面研究。
Int J Hematol Oncol Stem Cell Res. 2025 Apr 1;19(2):109-117. doi: 10.18502/ijhoscr.v19i2.18548.

本文引用的文献

1
Burden of Sickle Cell Disease in a Tertiary Care Hospital in Southern Rajasthan.拉贾斯坦邦南部一家三级护理医院中镰状细胞病的负担
Indian J Pediatr. 2023 Sep;90(9):950. doi: 10.1007/s12098-023-04674-x. Epub 2023 May 29.
2
Neonatal Screening and the Clinical Outcome in Children with Sickle Cell Disease in Central India.印度中部镰状细胞病患儿的新生儿筛查及临床结局
PLoS One. 2016 Jan 19;11(1):e0147081. doi: 10.1371/journal.pone.0147081. eCollection 2016.
3
Sickle cell disease in tribal populations in India.印度部落人群中的镰状细胞病。
Indian J Med Res. 2015 May;141(5):509-15. doi: 10.4103/0971-5916.159492.
4
Guidelines for screening, diagnosis and management of hemoglobinopathies.血红蛋白病的筛查、诊断及管理指南。
Indian J Hum Genet. 2014 Apr;20(2):101-19. doi: 10.4103/0971-6866.142841.
5
Feasibility of a newborn screening and follow-up programme for sickle cell disease among South Gujarat (India) tribal populations.印度古吉拉特邦南部部落人群镰状细胞病新生儿筛查及随访项目的可行性
J Med Screen. 2015 Mar;22(1):1-7. doi: 10.1177/0969141314557372. Epub 2014 Oct 23.
6
Screening for thalassemia and other hemoglobinopathies in a tertiary care hospital of West Bengal: implications for population screening.在孟加拉邦的一家三级保健医院进行地中海贫血症和其他血红蛋白病筛查:对人群筛查的影响。
Indian J Public Health. 2012 Oct-Dec;56(4):297-300. doi: 10.4103/0019-557X.106419.